# Healthcare Stocks Erase 25% Valuation Discount

> Healthcare stocks erase 25% valuation discount in a year as investors buy insurance against AI bubble.
- Title: Healthcare Stocks Erase 25% Valuation Discount · BigGo Finance
- Summary: Healthcare stocks erase 25% valuation discount in a year as investors buy insurance against AI bubble. Healthcare stocks have erased a 25% valuation discount…
- Keywords: healthcare stocks, s&p 500, xlv, ai bubble, valuation discount, goldman sachs, elijli, johnson & johnson, moderna, bristol-myers squibb, federal reserve, healthcare reform
- Source: BigGo Finance — https://finance.biggo.com/news/e6ee1dfa-c0e7-4a11-813b-cba85e368c14
- Author: BigGo Finance
- Published: 2026-10-22T18:27:46+00:00
- Read time: 1 min
- Topics: healthcare stocks, s&p 500, xlv, ai bubble, valuation discount, goldman sachs, elijli, johnson & johnson, moderna, bristol-myers squibb, federal reserve, healthcare reform
## Healthcare Stocks Surge
Healthcare stocks have become one of the strongest performers in the S&P 500 with XLV's forward price-to-earnings ratio rising to 19.3 times.
## AI Bubble Drives Shift
Investors are using healthcare stocks as a hedge against AI-driven selloffs amid rising interest rates.
## Valuation Recovery
XLV has erased a 25% valuation discount to the S&P 500 in one year, now trading at a premium of 19.3 times.
## Goldman Sachs Conditions
Goldman Sachs analysts say three conditions must hold: confidence in healthcare innovation, doubts about earnings sustainability, and contained policy uncertainty.
## Eli Lilly and Johnson & Johnson
Eli Lilly and Johnson & Johnson together account for roughly 25% of XLV's weighting, providing fundamental support.
## Historical Precedent
Investors who rotated into healthcare early in 2006 underperformed the broader market for nearly two years.
## 2004-2007 Cycle
In 2004-2007, healthcare commanded a premium as S&P 500's forward P/E fell from 18 to 15 times.
## Eli Lilly Growth
Eli Lilly is expected to grow sales by more than 30% this year due to strong demand for diabetes and obesity drugs.
## Policy Environment
More than ten pharmaceutical companies have reached agreements with the Trump administration for tariff exemptions.
## Key takeaway

Healthcare stocks have erased a 25% valuation discount from the S&P 500 in one year as investors seek safety amid AI bubble fears.